It's Now Even Easier to Prescribe HCV Treatments
Hepatitis C-related stigma and discrimination in a post-cure world
Hepatitis C-related stigma and discrimination in a post-cure world The project, 'Hepatitis C-related stigma and…Read Article
And the Winners Are...
And the Winners Are… We are thrilled to announce the winners of this year's World…Read Article
Prisons weakest link in the fight against blood borne viruses in Australia
The Harm Reduction in Prisons Working Group has released a consensus statement that outlines an…Read Article
Changes to the Pharmaceutical Benefits Scheme (PBS) from 1st April mean:
- virus genotype is no longer required before prescribing treatment, and
- the 18+ age restriction has also been removed.
Pangenotypic treatments, available under the PBS, are suitable for all hepatitis C genotypes. GPs can find more information about treating hepatitis C on our GP Resources page.